Compare WHD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHD | RLAY |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.1B |
| IPO Year | 2018 | 2020 |
| Metric | WHD | RLAY |
|---|---|---|
| Price | $55.12 | $18.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $56.33 | $19.50 |
| AVG Volume (30 Days) | 795.2K | ★ 3.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | 18.99 | ★ 31.78 |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,079,051,000.00 | $15,355,000.00 |
| Revenue This Year | $43.92 | N/A |
| Revenue Next Year | $6.83 | $324.03 |
| P/E Ratio | $291.53 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $33.30 | $3.03 |
| 52 Week High | $64.30 | $20.79 |
| Indicator | WHD | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 50.31 |
| Support Level | $52.51 | $6.67 |
| Resistance Level | $58.53 | $20.79 |
| Average True Range (ATR) | 1.52 | 1.20 |
| MACD | 0.53 | -0.28 |
| Stochastic Oscillator | 81.10 | 1.99 |
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.